agilon health, inc. (NYSE:AGL) Given Consensus Recommendation of “Hold” by Analysts

Shares of agilon health, inc. (NYSE:AGL) have received a consensus recommendation of “Hold” from the eighteen research firms that are currently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, twelve have issued a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is $4.81.

AGL has been the subject of a number of analyst reports. Cowen reaffirmed a “hold” rating on shares of agilon health in a research note on Tuesday, April 15th. Stifel Nicolaus boosted their target price on agilon health from $2.00 to $3.00 and gave the stock a “hold” rating in a research note on Wednesday, February 26th. Sanford C. Bernstein raised agilon health from a “market perform” rating to an “outperform” rating and boosted their target price for the stock from $3.30 to $8.50 in a research note on Tuesday, April 8th. Robert W. Baird lowered their target price on agilon health from $6.00 to $5.00 and set a “neutral” rating for the company in a research note on Tuesday, April 15th. Finally, TD Cowen boosted their target price on shares of agilon health from $3.50 to $6.00 and gave the stock a “hold” rating in a report on Tuesday, April 15th.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Capital International Investors boosted its holdings in shares of agilon health by 72.0% in the fourth quarter. Capital International Investors now owns 22,331,873 shares of the company’s stock worth $42,431,000 after acquiring an additional 9,346,295 shares during the period. Millennium Management LLC boosted its stake in agilon health by 187.8% during the fourth quarter. Millennium Management LLC now owns 7,212,525 shares of the company’s stock valued at $13,704,000 after buying an additional 4,706,357 shares during the period. Algert Global LLC boosted its stake in agilon health by 1,042.7% during the fourth quarter. Algert Global LLC now owns 2,108,687 shares of the company’s stock valued at $4,007,000 after buying an additional 1,924,157 shares during the period. Charles Schwab Investment Management Inc. boosted its stake in agilon health by 49.2% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 4,541,549 shares of the company’s stock valued at $8,629,000 after buying an additional 1,498,524 shares during the period. Finally, JPMorgan Chase & Co. boosted its stake in agilon health by 326.4% during the third quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company’s stock valued at $5,563,000 after buying an additional 1,083,492 shares during the period.

agilon health Trading Down 1.5 %

AGL stock opened at $3.84 on Tuesday. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. The company has a fifty day moving average price of $4.20 and a two-hundred day moving average price of $3.14. agilon health has a one year low of $1.50 and a one year high of $7.73. The stock has a market cap of $1.59 billion, a price-to-earnings ratio of -4.09 and a beta of 0.38.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.